Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 3
1953 2
1954 1
1955 1
1957 1
1958 5
1959 2
1960 3
1961 1
1962 2
1963 1
1965 1
1967 3
1968 2
1969 4
1970 2
1971 3
1972 2
1973 3
1975 3
1976 3
1977 4
1978 5
1979 10
1980 7
1981 12
1982 10
1983 11
1984 12
1985 17
1986 8
1987 15
1988 13
1989 16
1990 15
1991 18
1992 24
1993 17
1994 26
1995 20
1996 27
1997 25
1998 34
1999 35
2000 38
2001 22
2002 33
2003 26
2004 42
2005 30
2006 48
2007 55
2008 66
2009 72
2010 62
2011 81
2012 94
2013 96
2014 97
2015 102
2016 116
2017 110
2018 123
2019 119
2020 146
2021 173
2022 128
2023 130
2024 116
2025 47

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,352 results

Results by year

Filters applied: . Clear all
Page 1
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease.
Pavord ID, Chanez P, Criner GJ, Kerstjens HAM, Korn S, Lugogo N, Martinot JB, Sagara H, Albers FC, Bradford ES, Harris SS, Mayer B, Rubin DB, Yancey SW, Sciurba FC. Pavord ID, et al. Among authors: rubin db. N Engl J Med. 2017 Oct 26;377(17):1613-1629. doi: 10.1056/NEJMoa1708208. Epub 2017 Sep 11. N Engl J Med. 2017. PMID: 28893134 Free article. Clinical Trial.
Overview to Challenges in IBD 2024-2029.
Heller C, Moss AC, Rubin DT. Heller C, et al. Among authors: rubin dt. Inflamm Bowel Dis. 2024 May 23;30(Suppl 2):S1-S4. doi: 10.1093/ibd/izae092. Inflamm Bowel Dis. 2024. PMID: 38778626 Review.
Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial.
Ferrante M, Panaccione R, Baert F, Bossuyt P, Colombel JF, Danese S, Dubinsky M, Feagan BG, Hisamatsu T, Lim A, Lindsay JO, Loftus EV Jr, Panés J, Peyrin-Biroulet L, Ran Z, Rubin DT, Sandborn WJ, Schreiber S, Neimark E, Song A, Kligys K, Pang Y, Pivorunas V, Berg S, Duan WR, Huang B, Kalabic J, Liao X, Robinson A, Wallace K, D'Haens G. Ferrante M, et al. Among authors: rubin dt. Lancet. 2022 May 28;399(10340):2031-2046. doi: 10.1016/S0140-6736(22)00466-4. Lancet. 2022. PMID: 35644155 Clinical Trial.
Long-term safety of vedolizumab for inflammatory bowel disease.
Loftus EV Jr, Feagan BG, Panaccione R, Colombel JF, Sandborn WJ, Sands BE, Danese S, D'Haens G, Rubin DT, Shafran I, Parfionovas A, Rogers R, Lirio RA, Vermeire S. Loftus EV Jr, et al. Among authors: rubin dt. Aliment Pharmacol Ther. 2020 Oct;52(8):1353-1365. doi: 10.1111/apt.16060. Epub 2020 Sep 2. Aliment Pharmacol Ther. 2020. PMID: 32876349 Free PMC article. Clinical Trial.
Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting.
Parigi TL, D'Amico F, Abreu MT, Dignass A, Dotan I, Magro F, Griffiths AM, Jairath V, Iacucci M, Mantzaris GJ, O'Morain C, Reinisch W, Sachar DB, Turner D, Yamamoto T, Rubin DT, Peyrin-Biroulet L, Ghosh S, Danese S. Parigi TL, et al. Among authors: rubin dt. Lancet Gastroenterol Hepatol. 2023 Sep;8(9):853-859. doi: 10.1016/S2468-1253(23)00154-1. Epub 2023 Jul 6. Lancet Gastroenterol Hepatol. 2023. PMID: 37423233 Review.
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis.
Sands BE, Feagan BG, Peyrin-Biroulet L, Danese S, Rubin DT, Laurent O, Luo A, Nguyen DD, Lu J, Yen M, Leszczyszyn J, Kempiński R, McGovern DPB, Ma C, Ritter TE, Targan S; ARTEMIS-UC Study Group. Sands BE, et al. Among authors: rubin dt. N Engl J Med. 2024 Sep 26;391(12):1119-1129. doi: 10.1056/NEJMoa2314076. N Engl J Med. 2024. PMID: 39321363 Clinical Trial.
Aktualisierte S2k-Leitlinie chronische Obstipation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie & Motilität (DGNM) – April 2022 – AWMF-Registriernummer: 021–019.
Andresen V, Becker G, Frieling T, Goebel-Stengel M, Gundling F, Herold A, Karaus M, Keller J, Kim M, Klose P, Krammer H, Kreis ME, Kuhlbusch-Zicklam R, Langhorst J, Layer P, Lenzen-Großimlinghaus R, Madisch A, Mönnikes H, Müller-Lissner S, Rubin D, Schemann M, Schwille-Kiuntke J, Stengel A, Storr M, van der Voort I, Voderholzer W, Wedel T, Wirz S, Witzigmann H, Pehl C; In Zusammenarbeit mit:; Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV)/Chirurgische Arbeitsgemeinschaft für Coloproktologie (CACP); Deutsche Gesellschaft für Ernährungsmedizin (DGEM), Deutsche Gesellschaft für Naturheilkunde (DGNHK); Deutsche Gesellschaft für Geriatrie (DGG); Deutsche Gesellschaft für Koloproktologie (DGK); Deutsche Gesellschaft für Innere Medizin (DGIM); Deutsche Gesellschaft für Palliativmedizin e. V. (DGP); Deutsche Schmerzgesellschaft e. V., MAGDA Patientenforum (MAGDA). Andresen V, et al. Among authors: rubin d. Z Gastroenterol. 2022 Oct;60(10):1528-1572. doi: 10.1055/a-1880-1928. Epub 2022 Oct 12. Z Gastroenterol. 2022. PMID: 36223785 Free article. German. No abstract available.
Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis.
Shaw DG, Aguirre-Gamboa R, Vieira MC, Gona S, DiNardi N, Wang A, Dumaine A, Gelderloos-Arends J, Earley ZM, Meckel KR, Ciszewski C, Castillo A, Monroe K, Torres J, Shah SC, Colombel JF, Itzkowitz S, Newberry R, Cohen RD, Rubin DT, Quince C, Cobey S, Jonkers IH, Weber CR, Pekow J, Wilson PC, Barreiro LB, Jabri B. Shaw DG, et al. Among authors: rubin dt. Nat Med. 2023 Jun;29(6):1520-1529. doi: 10.1038/s41591-023-02372-x. Epub 2023 Jun 15. Nat Med. 2023. PMID: 37322120 Free PMC article.
2,352 results